A cost analysis of inpatient compared with outpatient prostaglandin E2 cervical priming for induction of labour: results from the OPRA trial

Aust Health Rev. 2013 Sep;37(4):467-73. doi: 10.1071/AH13081.

Abstract

Objective: To compare the costs of inpatient (usual care) with outpatient (intervention) care for cervical priming for induction of labour in women with healthy, low-risk pregnancies who are being induced for prolonged pregnancies or for social reasons.

Methods: Data from a randomised controlled trial at two hospitals in South Australia were matched with hospital financial data. A cost analysis comparing women randomised to inpatient care with those randomised to outpatient care was performed, with an additional analysis focusing on those who received the intervention.

Results: Overall, 48% of women randomised into the trial did not receive the intervention. Women randomised to outpatient care had an overall cost saving of $319 per woman (95% CI -$104 to $742) as compared with women randomised to usual care. When restricted to women who actually received the intervention, in-hospital cost savings of $433 (95% CI -$282 to $1148) were demonstrated in the outpatient group. However, these savings were partially offset by the cost of an outpatient priming clinic, reducing the overall cost savings to $156 per woman.

Conclusions: Overall cost savings were not statistically significant in women who were randomised to or received the intervention. However, the trend in cost savings favoured outpatient priming.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cervical Ripening* / drug effects
  • Confidence Intervals
  • Cost Savings
  • Costs and Cost Analysis / methods
  • Dinoprostone*
  • Female
  • Hospitalization / economics*
  • Humans
  • Labor, Induced / economics*
  • Outpatients*
  • Oxytocics*
  • Pregnancy
  • South Australia

Substances

  • Oxytocics
  • Dinoprostone